AI could spot breast cancer risk from family history alone

NCT ID NCT07070128

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Dec 18, 2025 · Last updated Jun 16, 2026 · Updated 20 times

Summary

This study is testing whether an artificial intelligence (AI) tool can accurately predict a woman's genetic risk of developing breast cancer by analyzing her family cancer history. Researchers will compare the AI's predictions with standard genetic test results in 800 women who have already been identified as high-risk by their doctors. The goal is to see if the AI tool can reliably identify who needs genetic counseling, potentially making risk assessment faster and more accessible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
WITHDRAWN

Golania, Goiás, 74605-020, Brazil
Research Site
RECRUITING

Porto Alegre, Rio Grande do Sul, 90035-001, Brazil
Research Site
NOT_YET_RECRUITING

Porto Alegre, Rio Grande do Sul, 90035-903, Brazil

Conditions

Explore the condition pages connected to this study.

BREAST NEOPLASMS BREAST NEOPLASMS

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

BREAST CANCER